- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China;
Citation: ZHUANG Hongyu, KONG Xianbing. Risk factors of posthepatectomy liver failure for hepatobiliary malignancies: a meta-analysis. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2021, 28(4): 477-487. doi: 10.7507/1007-9424.202007049 Copy
1. | Sultana A, Brooke-Smith M, Ullah S, et al. Prospective evaluation of the International Study Group for liver surgery definition of post hepatectomy liver failure after liver resection: an international multicentre study. HPB (Oxford), 2018, 20(5): 462-469. |
2. | Kauffmann R, Fong Y. Post-hepatectomy liver failure. Hepatobiliary Surg Nutr, 2014, 3(5): 238-246. |
3. | Wells GA, Shea B, O’Connell D, et al. NewCastle-Ottawa Quallty Assessment Scale—case control studies. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. |
4. | Kong FH, Miao XY, Zou H, et al. End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma. World J Clin Cases, 2019, 7(22): 3734-3741. |
5. | Yamamoto G, Taura K, Ikai I, et al. ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure. Surgery, 2020, 167(2): 410-416. |
6. | Wang H, Li L, Bo W, et al. Immediate postoperative fibrosis-4 predicts postoperative liver failure for patients with hepatocellular carcinoma undergoing curative surgery. Dig Liver Dis, 2018, 50(1): 61-67. |
7. | Nitta H, Kitano Y, Miyata T, et al. Validation of functional assessment for liver resection considering venous occlusive area after extended hepatectomy. J Gastrointest Surg, 2020, 24(7): 1510-1519. |
8. | Jo HS, Kim DS, Jung SW, et al. Clinical significance of post-hepatectomy hepatic failure in patients with liver metastases from colorectal cancer. Ann Hepatobiliary Pancreat Surg, 2018, 22(2): 93-100. |
9. | Nakamura I, Iimuro Y, Hai S, et al. Impaired value of 99mTc-GSA scintigraphy as an independent risk factor for posthepatectomy liver failure in patients with hepatocellular carcinoma. Eur Surg Res, 2018, 59(1-2): 12-22. |
10. | Lei JW, Ji XY, Hong JF, et al. Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma. BMC Gastroenterol, 2017, 17(1): 171. |
11. | Navarro JG, Yang SJ, Kang I, et al. What are the most important predictive factors for clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma? Ann Surg Treat Res, 2020, 98(2): 62-71. |
12. | Fukushima K, Fukumoto T, Kuramitsu K, et al. Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg, 2014, 18(4): 729-736. |
13. | Iguchi K, Hatano E, Yamanaka K, et al. The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg, 2014, 38(1): 150-158. |
14. | Olthof PB, Wiggers JK, Groot Koerkamp B, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg, 2017, 225(3): 387-394. |
15. | Mai RY, Ye JZ, Long ZR, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res, 2019, 11: 1401-1414. |
16. | Zhou SJ, Zhang EL, Liang BY, et al. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis. J Surg Res, 2016, 200(2): 444-451. |
17. | Chapelle T, Op de Beeck B, Driessen A, et al. Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores. Eur J Surg Oncol, 2017, 43(12): 2277-2284. |
18. | Nishio T, Taura K, Koyama Y, et al. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma. Surgery, 2016, 159(2): 399-408. |
19. | Peng W, Li J, Zhang X, et al. A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma. PLoS One, 2019, 14(7): e0219219. |
20. | Chen X, Zhai J, Cai X, et al. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg, 2012, 99(12): 1701-1710. |
21. | Lin XJ, Yang J, Chen XB, et al. The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients. J Surg Res, 2014, 188(2): 489-495. |
22. | Shen Y, Zhou C, Zhu G, et al. Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma. J Gastrointest Surg, 2017, 21(9): 1471-1479. |
23. | Miyazaki Y, Kokudo T, Amikura K, et al. Albumin-indocyanine green evaluation grading system predicts post-hepatectomy liver failure for biliary tract cancer. Dig Surg, 2019, 36(1): 13-19. |
24. | Tomimaru Y, Eguchi H, Gotoh K, et al. Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test. J Surg Oncol, 2016, 113(5): 565-569. |
25. | Jin YJ, Lee SH, Cho SG, et al. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. J Gastroenterol Hepatol, 2016, 31(7): 1349-1356. |
26. | 刘朔珲, 严俊, 张奇煜, 等. 白蛋白-胆红素评分联合标准化残肝体积比对肝细胞癌患者肝切除术后肝功能衰竭的预测价值. 中国普外基础与临床杂志, 2019, 26(5): 545-550. |
27. | 刘朝辉, 杜振双, 林建泉, 等. 原发性肝癌肝切除术后发生肝功能衰竭的围术期影响因素分析. 肝胆外科杂志, 2016, 24(5): 375-377. |
28. | 崔宏, 高琴琴, 王效益, 等. 肝细胞癌合并肝硬化患者肝切除术后标准残肝体积评估. 中国现代普通外科进展, 2019, 22(4): 296-299. |
29. | 张毅, 张杰峰, 张艳林, 等. 联合半肝切除的肝门部胆管癌根治术后发生急性肝衰竭的危险因素分析. 临床肝胆病杂志, 2016, 32(10): 1936-1938. |
30. | 徐逸昕, 金雷, 陆维军, 等. 原发性肝癌切除术后肝功能衰竭的临床分析. 常州实用医学, 2013, 29(4): 217-219. |
31. | 曾勇超, 戴朝六, 卜献民, 等. ALBI 评分与 Child-Pugh 评分对肝癌肝切除术后肝衰竭预测的比较. 中华普通外科杂志, 2019, 34(8): 649-651. |
32. | 曾柏强, 吴祥, 冉义洪, 等. 大范围肝切除术后肝衰竭危险因素分析. 中华肝脏外科手术学电子杂志, 2018, 7(2): 143-146. |
33. | 李昊, 张宏伟, 唐强, 等. 吲哚菁绿试验与白蛋白-胆红素评分对肝切除术后肝功能衰竭的预测作用. 中华实用诊断与治疗杂志, 2019, 33(11): 1069-1072. |
34. | 柳己海, 郑小林, 郑直, 等. 原发性肝癌肝切除术后患者发生肝功能衰竭的围术期危险因素分析. 中国全科医学, 2013, 16(17): 2036-2038. |
35. | 江勇, 汤建军, 远博. 大肝癌术后肝衰竭的防治. 医学研究杂志, 2011, 40(1): 77-79. |
36. | 熊邦文, 侯琨. 原发性肝癌肝切除后发生肝功能衰竭的围术期相关危险因素. 中国当代医药, 2013, 20(25): 12-13, 16. |
37. | 苏瑛, 龚昭. 肝癌伴胆管癌栓患者术后发生肝功能衰竭的影响因素研究. 实用癌症杂志, 2014, 29(2): 233-236. |
38. | 薄飞, 王燕, 杜建文. 白蛋白-胆红素评分、吲哚箐绿 15 min 清除率与肝癌肝切除后发生肝衰的关系. 中国普通外科杂志, 2020, 29(1): 115-119. |
39. | 许显志, 刘进忠, 李志锋, 等. 原发性肝癌肝切除术后发生肝功能衰竭的影响因素分析. 现代仪器与医疗, 2017, 23(4): 31-33. |
40. | 谭蔚锋, 罗祥基, 张蜀豫, 等. 肝癌伴胆管癌栓术后肝功能衰竭的危险因素分析. 中华消化外科杂志, 2013, 12(3): 217-221. |
41. | 邓香萍, 毛晓雪, 赵斌, 等. 原发性肝癌切除后患者血小板计数的恢复情况及临床意义. 中西医结合肝病杂志, 2018, 28(3): 173-175. |
42. | 金昌国, 杨滔, 董家鸿. 肝门部胆管癌大范围肝切除术前胆道引流作用的临床研究. 军事医学, 2013, 37(7): 529-534. |
43. | 陈绪涛, 翟健, 张一军, 等. Child-Pugh A 级肝细胞癌患者术后肝功能衰竭发生的危险因素分析. 肝胆外科杂志, 2012, 20(3): 170-173. |
44. | 韩秀国, 马宽生, 夏锋, 等. 肝硬化肝癌和无肝硬化肝癌患者围术期肝衰竭和死亡的相关因素分析. 中华消化外科杂志, 2016, 15(6): 605-614. |
45. | 高娟, 陈琳. 原发性肝癌肝切除患者肝功能衰竭围术期相关危险因素分析. 健康导报 (医学版), 2015, 20(7): 49. |
46. | 龚文锋, 陆战, 张志远, 等. 标准残肝体积预测肝癌合并肝硬化患者半肝切除术后肝功能衰竭的临床研究. 中国肿瘤临床, 2018, 45(5): 232-236. |
47. | Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg, 2005, 242(6): 824-828. |
48. | Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery, 2011, 149(5): 713-724. |
49. | Bernal W, Lee WM, Wendon J, et al. Acute liver failure: A curable disease by 2024? J Hepatol, 2015, 62(1 Suppl): S112-S120. |
50. | Yokoyama Y, Schwacha MG, Samy TS, et al. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res, 2002, 26(1-3): 63-76. |
51. | Rezvani R, Smith J, Lapointe m, et al. Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery. J Obes, 2014, 2014: 383102. |
52. | Langella S, Russolillo N, Forchino F, et al. Impact of obesity on postoperative outcome of hepatic resection for colorectal metastases. Surgery, 2015, 158(6): 1521-1529. |
53. | Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386. |
54. | Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int, 2017, 11(4): 317-370. |
55. | 陈述海, 董冰子, 冯玉杰, 等. 肝部分切除术后影响肝再生的临床病理学因素研究进展. 肝胆胰外科杂志, 2019, 31(7): 444-449. |
56. | 张东欣, 姜珊, 董家鸿. 大范围肝切除术后肝功能衰竭的研究进展. 中国现代普通外科进展, 2015, 18(4): 295-299. |
57. | Lisman T, Porte RJ. Mechanisms of platelet-mediated liver regeneration. Blood, 2016, 128(5): 625-629. |
58. | Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol, 2017, 23(18): 3228-3239. |
59. | Chen JS, Huang JQ, Chen XL, et al. Risk factors associated with intraoperative major blood loss during resection of hepatocellular carcinoma. Hepatogastroenterology, 2015, 62(140): 790-793. |
60. | Chapelle T, Op de Beeck B, Roeyen G, et al. Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study. HPB (Oxford), 2017, 19(2): 108-117. |
61. | Yokoyama Y, Ebata T, Igami T, et al. The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg, 2016, 40(6): 1440-1447. |
62. | Tanaka S, Iimuro Y, Hirano T, et al. Prediction of postoperative hepatic failure after liver resection for hepatocellular carcinoma: significance of the aspartate aminotransferase-to-platelet ratio index. Hepatogastroenterology, 2014, 61(131): 755-761. |
63. | Bennett S, Baker LK, Martel G, et al. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB (Oxford), 2017, 19(4): 321-330. |
64. | Shen Y, Wu SD, Wu L, et al. The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis. Hepatol Int, 2019, 13(5): 560-572. |
65. | Chebib FT, Harmon A, Irazabal Mira MV, et al. Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease. J Am Coll Surg, 2016, 223(1): 118-126. |
66. | Zheng Y, Yang H, He L, et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1 683 hepatectomy. Oncotarget, 2017, 8(51): 89269-89277. |
- 1. Sultana A, Brooke-Smith M, Ullah S, et al. Prospective evaluation of the International Study Group for liver surgery definition of post hepatectomy liver failure after liver resection: an international multicentre study. HPB (Oxford), 2018, 20(5): 462-469.
- 2. Kauffmann R, Fong Y. Post-hepatectomy liver failure. Hepatobiliary Surg Nutr, 2014, 3(5): 238-246.
- 3. Wells GA, Shea B, O’Connell D, et al. NewCastle-Ottawa Quallty Assessment Scale—case control studies. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- 4. Kong FH, Miao XY, Zou H, et al. End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma. World J Clin Cases, 2019, 7(22): 3734-3741.
- 5. Yamamoto G, Taura K, Ikai I, et al. ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failure. Surgery, 2020, 167(2): 410-416.
- 6. Wang H, Li L, Bo W, et al. Immediate postoperative fibrosis-4 predicts postoperative liver failure for patients with hepatocellular carcinoma undergoing curative surgery. Dig Liver Dis, 2018, 50(1): 61-67.
- 7. Nitta H, Kitano Y, Miyata T, et al. Validation of functional assessment for liver resection considering venous occlusive area after extended hepatectomy. J Gastrointest Surg, 2020, 24(7): 1510-1519.
- 8. Jo HS, Kim DS, Jung SW, et al. Clinical significance of post-hepatectomy hepatic failure in patients with liver metastases from colorectal cancer. Ann Hepatobiliary Pancreat Surg, 2018, 22(2): 93-100.
- 9. Nakamura I, Iimuro Y, Hai S, et al. Impaired value of 99mTc-GSA scintigraphy as an independent risk factor for posthepatectomy liver failure in patients with hepatocellular carcinoma. Eur Surg Res, 2018, 59(1-2): 12-22.
- 10. Lei JW, Ji XY, Hong JF, et al. Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma. BMC Gastroenterol, 2017, 17(1): 171.
- 11. Navarro JG, Yang SJ, Kang I, et al. What are the most important predictive factors for clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma? Ann Surg Treat Res, 2020, 98(2): 62-71.
- 12. Fukushima K, Fukumoto T, Kuramitsu K, et al. Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg, 2014, 18(4): 729-736.
- 13. Iguchi K, Hatano E, Yamanaka K, et al. The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg, 2014, 38(1): 150-158.
- 14. Olthof PB, Wiggers JK, Groot Koerkamp B, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg, 2017, 225(3): 387-394.
- 15. Mai RY, Ye JZ, Long ZR, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res, 2019, 11: 1401-1414.
- 16. Zhou SJ, Zhang EL, Liang BY, et al. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis. J Surg Res, 2016, 200(2): 444-451.
- 17. Chapelle T, Op de Beeck B, Driessen A, et al. Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores. Eur J Surg Oncol, 2017, 43(12): 2277-2284.
- 18. Nishio T, Taura K, Koyama Y, et al. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma. Surgery, 2016, 159(2): 399-408.
- 19. Peng W, Li J, Zhang X, et al. A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma. PLoS One, 2019, 14(7): e0219219.
- 20. Chen X, Zhai J, Cai X, et al. Severity of portal hypertension and prediction of postoperative liver failure after liver resection in patients with Child-Pugh grade A cirrhosis. Br J Surg, 2012, 99(12): 1701-1710.
- 21. Lin XJ, Yang J, Chen XB, et al. The critical value of remnant liver volume-to-body weight ratio to estimate posthepatectomy liver failure in cirrhotic patients. J Surg Res, 2014, 188(2): 489-495.
- 22. Shen Y, Zhou C, Zhu G, et al. Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma. J Gastrointest Surg, 2017, 21(9): 1471-1479.
- 23. Miyazaki Y, Kokudo T, Amikura K, et al. Albumin-indocyanine green evaluation grading system predicts post-hepatectomy liver failure for biliary tract cancer. Dig Surg, 2019, 36(1): 13-19.
- 24. Tomimaru Y, Eguchi H, Gotoh K, et al. Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test. J Surg Oncol, 2016, 113(5): 565-569.
- 25. Jin YJ, Lee SH, Cho SG, et al. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. J Gastroenterol Hepatol, 2016, 31(7): 1349-1356.
- 26. 刘朔珲, 严俊, 张奇煜, 等. 白蛋白-胆红素评分联合标准化残肝体积比对肝细胞癌患者肝切除术后肝功能衰竭的预测价值. 中国普外基础与临床杂志, 2019, 26(5): 545-550.
- 27. 刘朝辉, 杜振双, 林建泉, 等. 原发性肝癌肝切除术后发生肝功能衰竭的围术期影响因素分析. 肝胆外科杂志, 2016, 24(5): 375-377.
- 28. 崔宏, 高琴琴, 王效益, 等. 肝细胞癌合并肝硬化患者肝切除术后标准残肝体积评估. 中国现代普通外科进展, 2019, 22(4): 296-299.
- 29. 张毅, 张杰峰, 张艳林, 等. 联合半肝切除的肝门部胆管癌根治术后发生急性肝衰竭的危险因素分析. 临床肝胆病杂志, 2016, 32(10): 1936-1938.
- 30. 徐逸昕, 金雷, 陆维军, 等. 原发性肝癌切除术后肝功能衰竭的临床分析. 常州实用医学, 2013, 29(4): 217-219.
- 31. 曾勇超, 戴朝六, 卜献民, 等. ALBI 评分与 Child-Pugh 评分对肝癌肝切除术后肝衰竭预测的比较. 中华普通外科杂志, 2019, 34(8): 649-651.
- 32. 曾柏强, 吴祥, 冉义洪, 等. 大范围肝切除术后肝衰竭危险因素分析. 中华肝脏外科手术学电子杂志, 2018, 7(2): 143-146.
- 33. 李昊, 张宏伟, 唐强, 等. 吲哚菁绿试验与白蛋白-胆红素评分对肝切除术后肝功能衰竭的预测作用. 中华实用诊断与治疗杂志, 2019, 33(11): 1069-1072.
- 34. 柳己海, 郑小林, 郑直, 等. 原发性肝癌肝切除术后患者发生肝功能衰竭的围术期危险因素分析. 中国全科医学, 2013, 16(17): 2036-2038.
- 35. 江勇, 汤建军, 远博. 大肝癌术后肝衰竭的防治. 医学研究杂志, 2011, 40(1): 77-79.
- 36. 熊邦文, 侯琨. 原发性肝癌肝切除后发生肝功能衰竭的围术期相关危险因素. 中国当代医药, 2013, 20(25): 12-13, 16.
- 37. 苏瑛, 龚昭. 肝癌伴胆管癌栓患者术后发生肝功能衰竭的影响因素研究. 实用癌症杂志, 2014, 29(2): 233-236.
- 38. 薄飞, 王燕, 杜建文. 白蛋白-胆红素评分、吲哚箐绿 15 min 清除率与肝癌肝切除后发生肝衰的关系. 中国普通外科杂志, 2020, 29(1): 115-119.
- 39. 许显志, 刘进忠, 李志锋, 等. 原发性肝癌肝切除术后发生肝功能衰竭的影响因素分析. 现代仪器与医疗, 2017, 23(4): 31-33.
- 40. 谭蔚锋, 罗祥基, 张蜀豫, 等. 肝癌伴胆管癌栓术后肝功能衰竭的危险因素分析. 中华消化外科杂志, 2013, 12(3): 217-221.
- 41. 邓香萍, 毛晓雪, 赵斌, 等. 原发性肝癌切除后患者血小板计数的恢复情况及临床意义. 中西医结合肝病杂志, 2018, 28(3): 173-175.
- 42. 金昌国, 杨滔, 董家鸿. 肝门部胆管癌大范围肝切除术前胆道引流作用的临床研究. 军事医学, 2013, 37(7): 529-534.
- 43. 陈绪涛, 翟健, 张一军, 等. Child-Pugh A 级肝细胞癌患者术后肝功能衰竭发生的危险因素分析. 肝胆外科杂志, 2012, 20(3): 170-173.
- 44. 韩秀国, 马宽生, 夏锋, 等. 肝硬化肝癌和无肝硬化肝癌患者围术期肝衰竭和死亡的相关因素分析. 中华消化外科杂志, 2016, 15(6): 605-614.
- 45. 高娟, 陈琳. 原发性肝癌肝切除患者肝功能衰竭围术期相关危险因素分析. 健康导报 (医学版), 2015, 20(7): 49.
- 46. 龚文锋, 陆战, 张志远, 等. 标准残肝体积预测肝癌合并肝硬化患者半肝切除术后肝功能衰竭的临床研究. 中国肿瘤临床, 2018, 45(5): 232-236.
- 47. Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg, 2005, 242(6): 824-828.
- 48. Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery, 2011, 149(5): 713-724.
- 49. Bernal W, Lee WM, Wendon J, et al. Acute liver failure: A curable disease by 2024? J Hepatol, 2015, 62(1 Suppl): S112-S120.
- 50. Yokoyama Y, Schwacha MG, Samy TS, et al. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res, 2002, 26(1-3): 63-76.
- 51. Rezvani R, Smith J, Lapointe m, et al. Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery. J Obes, 2014, 2014: 383102.
- 52. Langella S, Russolillo N, Forchino F, et al. Impact of obesity on postoperative outcome of hepatic resection for colorectal metastases. Surgery, 2015, 158(6): 1521-1529.
- 53. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
- 54. Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int, 2017, 11(4): 317-370.
- 55. 陈述海, 董冰子, 冯玉杰, 等. 肝部分切除术后影响肝再生的临床病理学因素研究进展. 肝胆胰外科杂志, 2019, 31(7): 444-449.
- 56. 张东欣, 姜珊, 董家鸿. 大范围肝切除术后肝功能衰竭的研究进展. 中国现代普通外科进展, 2015, 18(4): 295-299.
- 57. Lisman T, Porte RJ. Mechanisms of platelet-mediated liver regeneration. Blood, 2016, 128(5): 625-629.
- 58. Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol, 2017, 23(18): 3228-3239.
- 59. Chen JS, Huang JQ, Chen XL, et al. Risk factors associated with intraoperative major blood loss during resection of hepatocellular carcinoma. Hepatogastroenterology, 2015, 62(140): 790-793.
- 60. Chapelle T, Op de Beeck B, Roeyen G, et al. Measuring future liver remnant function prior to hepatectomy may guide the indication for portal vein occlusion and avoid posthepatectomy liver failure: a prospective interventional study. HPB (Oxford), 2017, 19(2): 108-117.
- 61. Yokoyama Y, Ebata T, Igami T, et al. The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg, 2016, 40(6): 1440-1447.
- 62. Tanaka S, Iimuro Y, Hirano T, et al. Prediction of postoperative hepatic failure after liver resection for hepatocellular carcinoma: significance of the aspartate aminotransferase-to-platelet ratio index. Hepatogastroenterology, 2014, 61(131): 755-761.
- 63. Bennett S, Baker LK, Martel G, et al. The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review. HPB (Oxford), 2017, 19(4): 321-330.
- 64. Shen Y, Wu SD, Wu L, et al. The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis. Hepatol Int, 2019, 13(5): 560-572.
- 65. Chebib FT, Harmon A, Irazabal Mira MV, et al. Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease. J Am Coll Surg, 2016, 223(1): 118-126.
- 66. Zheng Y, Yang H, He L, et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1 683 hepatectomy. Oncotarget, 2017, 8(51): 89269-89277.
-
Previous Article
Subxiphoid and subcostal arch thoracoscopic versus unilateral thoracoscopic thymectomy for the treatment of thymic abnormalities with myasthenia gravis: A propensity-score matching study -
Next Article
Role of secretory protein GREM1 in systemic-to-pulmonary shunt associated pulmonary arterial hypertension